Shares of Novavax Inc. NVAX slid 3.09% to $7.83 Wednesday, on what proved to be an all-around mixed trading session for the ...

Novavax Stock Performance Shares of NVAX stock opened at $8.19 on Wednesday. The firm has a market cap of $1.31 billion, a price-to-earnings ratio of -3.62, a P/E/G ratio of 63.06 and a beta of 2.14.

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock. The average of price targets set by Wall Street analysts ...

today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) to prevent COVID-19 in individuals aged 12 and older are in stock at major pharmacy ...

Tribune News Service The chief executives of General Motors Co. and Ford Motor Co. made recent pilgrimages to Washington to ...

Matthew T. Hall writes that Kennedy’s U-turns on vaccinations and abortions should concern everyone following his close ...